Abstract:BACKGROUND: The grading of oral epithelial dysplasia is not possible in the atrophic epithelium of oral submucous fibrosis (OSMF). Recently, we found that features such as increased basal cell layer hyperplasia, abnormal superficial mitosis, increased nuclear-cytoplasmic ratio, increased nuclear size, and hyperchromasia represent transformation-relevant dysplastic features in the atrophic epithelium of OSMF. The presence of these features can be considered a high-risk feature for patients. However, these findings have not been tested and authenticated using markers relevant to oral carcinogenesis.METHOD: Paraffin-embedded tissues from 30 normal oral mucosa (NOM) and 50 OSMF were retrieved from 2008 to 2016 and subjected to immunohistochemical expression using Ki67, CD105 and α-SMA antibodies.RESULTS: Ki67 LI showed significant increases from NOM (12.47±2.34) to LRED (23.47±3.75) to HRED (34.31±7.31) (<0.0001). Similarly, MVD was increased significantly from NOM (3.53±5.17) to LRED (27.57±12.25) to HRED (46.18±12.55) (p<0.0001). The expression of α-SMA was significantly increased from LRED (0.21±0.41) to HRED (1.13±0.56) (<0.0001). The Ki67 LI and α-SMA; MVD and α-SMA; and Ki67Ki67 LI and MVD in NOM, LRED and HRED showed a statistically significant positive correlation (P<0.0001). The increase in Ki67 LI was directly proportional to MVD and α-SMA expression from NOM to LRED to HRED (P<0.0001). The connective tissue stroma of NOM lacks α-SMA expression. Mild myofibroblast expression was noted in 4 cases of LRED (14.28%) and in 18 cases of HRED (81.81%). Moderate expression was noted only in 4 cases of HRED (22.22%).CONCLUSION: Ki67 LI, CD105, and α-SMA expression showed significant differences between normal, LRED and HRED. These findings further support that features such as increased basal cell layer hyperplasia, abnormal superficial mitosis, increased nuclear-cytoplasmic ratio, and hyperchromasia could be transformation-relevant dysplastic features.

Proliferative Ability and Accumulation of Cancer Stem Cells in Oral Submucous Fibrosis Epithelium.

Loss of oral mucosal stem cell markers in oral submucous fibrosis and their reactivation in malignant transformation

The interplay of EMT and stemness driving malignant transformation of Oral Submucous Fibrosis

Evaluation of stromal myofibroblasts in oral submucous fibrosis and its malignant transformation: An immunohistochemical study

Mechanisms and markers of malignant transformation of oral submucous fibrosis

Senescent Epithelial Cells Remodel the Microenvironment for the Progression of Oral Submucous Fibrosis Through Secreting TGF-(31

Fibrotic Matrix Induces Mesenchymal Transformation of Epithelial Cells in Oral Submucous Fibrosis

Molecules of G2/M Phase and the Phosphorylation of Survivin in the Carcinogenesis of Oral Submucosal Fibrosis

Ki67, CD105, and α-SMA expression supports the transformation relevant dysplastic features in the atrophic epithelium of oral submucous fibrosis

Senescent Fibroblast in Oral Submucous Fibrosis Aids in Disease Progression and Malignant Transformation

The role of epithelial-mesenchymal transition in oral squamous cell carcinoma and oral submucous fibrosis.

Survivin As a Potential Early Marker in the Carcinogenesis of Oral Submucous Fibrosis

Deregulation of Secreted Frizzled-Related Proteins is Associated with Aberrant Β-Catenin Activation in the Carcinogenesis of Oral Submucous Fibrosis.

Identification of a BRAF/PA28γ/MEK1 Signaling Axis and Its Role in Epithelial-Mesenchymal Transition in Oral Submucous Fibrosis

Isolation of Cells with Morphological and Spatial Information from Oral Submucous Fibrosis Samples by Laser Capture Microdissection.

Clinicopathological Significance of Cancer Stem Cell Markers (OCT-3/4 and SOX-2) in Oral Submucous Fibrosis and Oral Squamous Cell Carcinoma

Early Histopathology In Oral Submucous Fibrosis (OSF) To Rule The Possibility Of Epithelial Dysplasia - Report Of Two Cases

Overexpression of DEC1 in the Epithelium of OSF Promotes Mesenchymal Transition Via Activating FAK/Akt Signal Axis.

Spatial Transcriptomic and Metabolomic Landscapes of Oral Submucous Fibrosis-Derived Oral Squamous Cell Carcinoma and its Tumor Microenvironment

Gene Expression Profiling of Oral Submucous Fibrosis Using Oligonucleotide Microarray

Expression of Ki67 as potential biomarker in oral submucous fibrosis: An immunohistochemical study